LY-03021

N/A

Report date: 2025/12/29 09:41:31
NMEFirst In Class

Base Information

Drug NameLY-03021
Drug Alias NameLY-03021LY03021LPM-682000012LPM682000012
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Steroids
Mechanisms of ActionNorepinephrine transporter inhibitorsDopamine reuptake inhibitorsGamma-aminobutyric acid A receptor positive allosteric modulators
TargetsNorepinephrine transporterDopamine transporterGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSchizophreniaAffective Disorders, PsychoticDepressive Disorder, Major +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLuye Pharma Group LtdShandong Luye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaAffective Disorders, PsychoticDepressive Disorder, Major +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A